Century Therapeutics (IPSC) EBITDA (2020 - 2026)
Century Therapeutics (IPSC) reported EBITDA of -$22.3 million for Q1 2026, down 129.08% year-over-year from $76.5 million in Q1 2025, and down 15.91% quarter-over-quarter from -$19.2 million in Q4 2025.
Century Therapeutics (IPSC) EBITDA (2020 - 2026) Analysis & Trends
Century Therapeutics (IPSC) has 7 years of EBITDA data on file, last reported at -$22.3 million in Q1 2026.
- EBITDA for Q1 2026 came in at -$22.3 million, down 129.08% year-over-year; the trailing twelve-month figure through Mar 2026 was -$108.7 million (down 407.8% YoY), and the FY2025 annual result was -$9.9 million, up 92.19% from the prior year.
- EBITDA declined to -$22.3 million in Q1 2026 per IPSC's latest filing, from -$19.2 million in the prior quarter.
- Over five years, EBITDA peaked at $76.5 million in Q1 2025 and troughed at -$39.5 million in Q1 2022.
- A 5-year average of -$25.0 million and a median of -$31.3 million in 2024 frame the typical range for EBITDA.
- The sharpest annual moves came in 2025 and 2026: EBITDA soared 369.41% in 2025, then slumped 129.08% in 2026.
- A 5-year view of EBITDA shows it stood at -$30.5 million in 2022, then declined by 24.37% to -$38.0 million in 2023, then climbed by 3.89% to -$36.5 million in 2024, then jumped by 47.39% to -$19.2 million in 2025, then decreased by 15.91% to -$22.3 million in 2026.
- Business Quant data shows IPSC's EBITDA at -$22.3 million in Q1 2026, -$19.2 million in Q4 2025, and -$34.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.92 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -13.63 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -752,618.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | Century Therapeutics | 444.99 Mn | 444.99 Mn | - | -22.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.26 Mn |
| Dec 31, 2025 | -19.21 Mn |
| Sep 30, 2025 | -34.44 Mn |
| Jun 30, 2025 | -32.76 Mn |
| Mar 31, 2025 | 76.54 Mn |
| Dec 31, 2024 | -36.51 Mn |
| Sep 30, 2024 | -30.16 Mn |
| Jun 30, 2024 | -31.28 Mn |
| Mar 31, 2024 | -28.41 Mn |
| Dec 31, 2023 | -37.98 Mn |
| Sep 30, 2023 | -32.82 Mn |
| Jun 30, 2023 | -33.22 Mn |
| Mar 31, 2023 | -30.08 Mn |
| Dec 31, 2022 | -30.54 Mn |
| Sep 30, 2022 | -30.92 Mn |
| Jun 30, 2022 | -31.78 Mn |
| Mar 31, 2022 | -39.51 Mn |
| Dec 31, 2021 | -28.78 Mn |
| Sep 30, 2021 | -26.07 Mn |
| Jun 30, 2021 | -23.25 Mn |